New technologies can potentially save lives by helping identify prostate cancer earlier, and transforming the way doctors detect and track cancerous cells. Prostate cancer is the most common cancer ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric, next-generation AI TechBio company and precision medicine ...

Partnership with Guardant Health expands access to multi-cancer screening as precision diagnostics emerges as a new growth ...

The FDA could approve the first blood test that can detect multiple cancers, around the end of the year, setting the stage ...

Stockholm3 blood test detected 90% of aggressive prostate cancer cases compared to 74% for PSA tests in a study of over ...

Cancer claims more than 10 million lives every year globally. Research shows that detecting cancer early can greatly improve a patient's chance of survival. And yet we lack reliable, affordable tools ...

Cancer of the voice box or larynx is an important public health burden. In 2021, there were an estimated 1.1 million cases of laryngeal cancer worldwide, and approximately 100,000 people died from it.

Adding aminopeptidase N and polymeric immunoglobin receptor to a plasma biomarker panel of carbohydrate antigen 19-9 (CA19-9) and thrombospondin 2 (THBS2) enhanced the detection of early-stage ...

More cases of colorectal cancer are detected at an early stage with screening. This is according to new research based on data from over 278,000 60-year-olds, who were randomly selected to undergo one ...